OptimizeRx Corp — Director's Dealing 2016

Feb 2, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2016-02-01

Reporting Person: Brooks James M (SVP of Business Development)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-01	Stock Option	$1.32	A	300000	Acquired	2018-12-04	Common Stock (300000)	Direct

Footnotes

F1: The stock option vests in increments upon the attainment of certain operational and financial milestones of the Issuer.